-
Trump says Iran wants deal, US 'armada' larger than in Venezuela raid
-
US Justice Dept releases new batch of documents, images, videos from Epstein files
-
Four memorable showdowns between Alcaraz and Djokovic
-
Russian figure skating prodigy Valieva set for comeback -- but not at Olympics
-
Barcelona midfielder Lopez agrees contract extension
-
Djokovic says 'keep writing me off' after beating Sinner in late-nighter
-
US Justice Dept releasing new batch of Epstein files
-
South Africa and Israel expel envoys in deepening feud
-
French eyewear maker in spotlight after presidential showing
-
Olympic dream 'not over', Vonn says after crash
-
Brazil's Lula discharged after cataract surgery
-
US Senate races to limit shutdown fallout as Trump-backed deal stalls
-
'He probably would've survived': Iran targeting hospitals in crackdown
-
Djokovic stuns Sinner to set up Australian Open final with Alcaraz
-
Mateta omitted from Palace squad to face Forest
-
Gold, silver prices tumble as investors soothed by Trump's Fed pick
-
Trump attorney general orders arrest of ex-CNN anchor covering protests
-
Djokovic 'pushed to the limit' in stunning late-night Sinner upset
-
Tunisia's famed blue-and-white village threatened after record rains
-
Top EU official voices 'shock' at Minneapolis violence
-
Kremlin says agreed to halt strikes on Kyiv until Sunday
-
Carrick calls for calm after flying start to Man Utd reign
-
Djokovic to meet Alcaraz in Melbourne final after five-set marathon
-
Italian officials to testify in trial over deadly migrant shipwreck
-
Iran says defence capabilities 'never' up for negotiation
-
UN appeals for more support for flood-hit Mozambicans
-
Lijnders urges Man City to pile pressure on Arsenal in title race
-
Fulham sign Man City winger Oscar Bobb
-
Strasbourg's Argentine striker Panichelli sets sights on PSG, World Cup
-
Jesus 'made love': Colombian president irks Christians with steamy claim
-
IAEA board meets over Ukraine nuclear safety concerns
-
Eurozone growth beats 2025 forecasts despite Trump woes
-
Israel to partially reopen Gaza's Rafah crossing on Sunday
-
Dutch PM-elect Jetten says not yet time to talk to Putin
-
Social media fuels surge in UK men seeking testosterone jabs
-
Forest face Fenerbahce, Celtic draw Stuttgart in Europa League play-offs
-
US speed queen Vonn crashes at Crans-Montana, one week before Olympics
-
Trump nominates former US Fed official as next central bank chief
-
Alcaraz defends controversial timeout after beaten Zverev fumes
-
New Dutch government pledges ongoing Ukraine support
-
Newcastle still coping with fallout from Isak exit, says Howe
-
Chad, France eye economic cooperation as they reset strained ties
-
Real Madrid to play Benfica, PSG face Monaco in Champions League play-offs
-
Everton winger Grealish set to miss rest of season in World Cup blow
-
Trump brands Minneapolis nurse killed by federal agents an 'agitator'
-
Arteta focuses on the positives despite Arsenal stumble
-
Fijian Drua sign France international back Vakatawa
-
Kevin Warsh, a former Fed 'hawk' now in tune with Trump
-
Zverev rails at Alcaraz timeout in 'one of the best battles ever'
-
Turkey leads Iran diplomatic push as Trump softens strike threat
| RBGPF | 1.65% | 83.78 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| RYCEF | -2.69% | 16 | $ | |
| CMSC | 0.02% | 23.7 | $ | |
| BCC | -0.97% | 79.4 | $ | |
| BTI | -0.12% | 60.135 | $ | |
| RELX | -1.69% | 35.565 | $ | |
| NGG | -0.81% | 84.37 | $ | |
| GSK | 1.33% | 51.34 | $ | |
| RIO | -4.86% | 90.725 | $ | |
| JRI | 0.32% | 12.997 | $ | |
| CMSD | -0.12% | 24.03 | $ | |
| BCE | -0.18% | 25.44 | $ | |
| VOD | -0.58% | 14.625 | $ | |
| AZN | 0.75% | 93.285 | $ | |
| BP | -1.1% | 37.625 | $ |
Climate change, population growth threats as malaria fight stalls
The fight against malaria has stalled after two decades of progress, with climate change and population growth among factors threatening a resurgence of the potentially fatal disease, campaigners said Tuesday.
Insufficient funding for increasingly costly prevention programmes risked efforts against the mosquito-borne illness at a cost of hundreds of thousands of lives and billions of dollars, they said.
The impact would be most keenly felt in Africa which accounts for 95 percent of cases of the disease that claimed 590,000 deaths worldwide in 2023, the African Leaders Malaria Alliance (ALMA) and Malaria No More UK said in a new report.
Several African countries had reported upsurges in cases between January and June 2025 after heavy rainfalls, they said.
Malaria mortality has halved over the past two decades, said the report released ahead of a November 21 meeting in South Africa to secure contributions to the Global Fund to Fight AIDS, TB and Malaria, which covers 59 percent of malaria spending.
"Insufficient funding, however, has caused malaria progress to stall," it said.
"A perfect storm of climate change, rising drug and insecticide resistance, trade disruptions, and global insecurity further undermine the efficacy of malaria interventions."
There were around 263 million cases of malaria globally in 2023, an increase of 11 million cases from the previous year, according to the UN's World Malaria Report 2024.
- Spreading -
"Increases in temperature and flooding due to climate change have increased the number of mosquito breeding sites," ALMA executive secretary Joy Phumaphi told AFP.
In Rwanda, for example, these sites now existed at higher altitudes than previously, she said in an interview.
The malaria-carrying Anopheles stephensi mosquito from Asia has meanwhile spread into Africa while insecticide resistance has increased, she said.
New-generation prevention methods, such as dual-insecticide mosquito nets and the use of drones to disperse chemicals that kill mosquito larva, were effective but also more costly, she said.
At the same time, Africa's population had almost doubled in the past 30 years. "It's more expensive, but we also have to cover a bigger population than before," Phumaphi said.
Malaria -- most prevalent in Nigeria -- is a leading cause of worker and student absenteeism, and also causes learning and cognitive disruption in children.
Besides saving lives, ridding countries of the disease would have "massive" returns on economies, including by boosting productivity and tourism, Phumaphi said.
Malaria "leads to huge amounts of out-of-pocket payments for households and is a major cause of poverty," she said. "Once this market is protected, their purchasing power is enormous."
An anti-malaria vaccine in use in 23 African countries was around 40 percent effective and had to be accompanied by other prevention measures. But a new vaccine undergoing human trials was hoped to show 80 percent efficacy, she said.
Funding modelling showed that a halt in all prevention interventions could cost Africa $83 billion in lost GDP by 2030, alongside 525 million additional cases and 990,000 more deaths on top of the already high annual toll, the report said.
T.Perez--AT